Science News

COVID-19 Professional Resources
The AHA is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with COVID-19. Here are some helpful resources for health systems, clinics, care providers, patients and the public.
HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19
03/16/2020 | Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with coronavirus disease 2019 (COVID-19).
Public Comment: 2020 ACC/AHA Performance Measures for Adult with Heart Failure
02/07/2020 | We would like to invite you to participate in the review of the draft version of the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults with Heart Failure.
HYPERTENSION | Trending Topics | January 2020
02/06/2020 | Hypertension Trending Topics for January 2020 Level of Physical Activity, Left Ventricular Mass, Hypertension, and Prognosis In Utero Antihypertensive Medication Exposure and Neonatal Outcomes: A Data Linkage Cohort Study
The AHA 2030 Impact Goal
01/29/2020 | Since the late 1990s, the AHA has committed to a singular impact goal to advance the AHA?s mission for the decade ahead.
Heart Disease and Stroke Statistics - 2020 Update
01/29/2020 | The age-adjusted death rate attributable to cardiovascular disease (CVD), based on 2017 data, is 219.4 per 100,000.
CIRCULATION RESEARCH | Featured Articles | November 2019
11/11/2019 | CIRCULATION RESEARCH Featured articles for November 2019
ATVB | Featured Articles | November 2019
10/25/2019 | ATVB September 2019 Editor's Pick and Featured Article
ATVB | Featured Articles | October 2019
09/26/2019 | ATVB September 2019 Editor's Pick and Featured Article